Physician profile
Fernando Caumont
NPI 1023533064
$29,688.17
in general payments reported to CMS, 2019-2025
39 companies · $3,856 in 2025
The $3,856 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $212 · 2020: $687 · 2021: $1,401 · 2022: $1,373 · 2023: $20K · 2024: $1,914 · 2025: $3,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $6,892 · Food and Beverage: $6,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,896.46 |
| Travel and Lodging | $6,891.60 |
| Food and Beverage | $6,227.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edap Technomed INC | $21,939.19 | 2020-2025 | |
| Procept Biorobotics Corporation | $1,122.35 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Janssen Biotech, INC. | $906.09 | 2020-2025 | Erleada, Carvykti, Rybrevant |
| Teleflex LLC | $810.59 | 2022-2024 | Urolift |
| Dendreon Pharmaceuticals LLC | $411.18 | 2019-2025 | Provenge |
| Sumitomo Pharma America, INC. | $405.34 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $372.48 | 2021-2025 | Jelmyto |
| Olympus America INC. | $361.89 | 2023-2025 | Itind System |
| Astellas Pharma US INC | $331.49 | 2019-2025 | Xtandi |
| Pfizer INC. | $325.12 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $300.17 | 2020-2025 | Prolaris, Myrisk |
| Abbvie INC. | $252.07 | 2022-2025 | Lupron Depot, Botox |
| Accord Healthcare, INC. | $211.04 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $210.44 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Antares Pharma, INC. | $175.91 | 2019-2023 | Xyosted, Tlando, Nocdurna |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $162.05 | 2023-2025 | Speedicath |
| Ferring Pharmaceuticals INC. | $144.84 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $141.67 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $130.58 | 2023-2025 | Posluma |
| Tolmar, INC. | $129.02 | 2023-2025 | Jatenzo, Eligard |
| Endo Pharmaceuticals INC. | $108.64 | 2020-2022 | |
| Medtronic, INC. | $81.73 | 2023-2024 | Interstim |
| Tolmar Pharmaceuticals, INC. | $77.24 | 2019-2022 | |
| Boston Scientific Corporation | $72.15 | 2024-2025 | General - Female Sui |
| Myovant Sciences INC. | $71.74 | 2021-2022 | |
| Urovant Sciences INC | $59.72 | 2022 | |
| Baxter Healthcare | $54.48 | 2024 | Floseal |
| Civco Medical Instruments | $46.29 | 2025 | |
| Clarus Therapeutics INC. | $45.00 | 2021 | |
| Dentsply Ih INC. | $44.59 | 2022 | |
| Telix Pharmaceuticals | $31.88 | 2023-2025 | Illuccix |
| Novartis Pharmaceuticals Corporation | $25.17 | 2022 | |
| Valencia Technologies Corporation | $22.75 | 2025 | Ecoin Device Kit |
| Janssen Scientific Affairs, LLC | $20.11 | 2019 | |
| Janssen Pharmaceuticals, INC | $18.94 | 2020 | |
| Neotract INC. | $18.25 | 2020 | |
| Ambu INC. | $16.68 | 2024 | |
| Immunitybio, INC. | $14.94 | 2024 | |
| Zyla Life Sciences, INC. | $14.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Caumont listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.